PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) – Get ready to dive into the future of healthcare with Integra LifeSciences Holdings Corporation (NASDAQ: IART), a global powerhouse in the realm of medical technology. The spotlight is on, and we’re thrilled to announce that Lea Knight, our Chief Financial Officer, will be your guide on this captivating journey.
On September 6, 2023, at 1:30 p.m. EST, Lea Knight will take center stage at the prestigious 2023 Wells Fargo Healthcare Conference. It’s not just a presentation; it’s a glimpse into the world of innovation and transformation. Join us and discover how Integra LifeSciences is shaping the future of medical technology!
About Integra LifeSciences
At Integra LifeSciences, we’re not just in the business of medical technology; we’re in the business of transforming lives. Our mission is simple yet profound: to restore the essence of what it means to be human – our health.
Picture this: A world where surgical, neurologic, and regenerative care aren’t just treatments; they’re gateways to a better life. We’re not content with the status quo; we’re pioneering new pathways to elevate patient outcomes, one breakthrough at a time.
Our arsenal is vast and powerful, featuring a comprehensive portfolio of renowned brands like AmnioExcel®, Aurora®, Bactiseal®, and many more. Each one is a testament to our commitment to quality and innovation.
But it’s not just about the products; it’s about the impact. From improving surgical procedures to enhancing neurological care, we’re raising the bar. We don’t just set standards; we redefine them.
At Integra LifeSciences, we’re not just a company; we’re a promise. A promise to put patients first, always. Join us on this journey as we reshape the future of healthcare, one remarkable achievement at a time.